Assessment of effects of beta-blocking drugs on blood glucose levels and insulin hypoglycaemia in rats.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001549:Benzamides / Q000008:administration & dosage / Q000494:pharmacology; D001786:Blood Glucose; D003408:Cresols / Q000008:administration & dosage / Q000494:pharmacology; D004347:Drug Interactions; D007003:Hypoglycemia / Q000139:chemically induced*; D007274:Injections, Intraperitoneal; D007328:Insulin; D007329:Insulin Antagonists; D008297:Male; D011217:Practolol / Q000494:pharmacology; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats
D000319:Adrenergic beta-Antagonists; D001549:Benzamides; D001786:Blood Glucose; D003408:Cresols; D007328:Insulin; D007329:Insulin Antagonists; D011412:Propanolamines; D011433:Propranolol; D011217:Practolol